Literature DB >> 2824704

Advanced non-small-cell lung cancer: to treat or not to treat?

H H Hansen.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 2824704     DOI： 10.1200/JCO.1987.5.11.1711

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Phase II study of (glycolate-O,O') diammineplatinum(II), a novel platinum complex, in the treatment of non-small-cell lung cancer.

Authors:  M Fukuda; T Shinkai; K Eguchi; Y Sasaki; T Tamura; Y Ohe; A Kojima; F Oshita; K Hara; N Saijo
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  A randomized trial fo three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group.

Authors:  L Crino; M Tonato; S Darwish; M L Meacci; E Corgna; F Di Costanzo; F Buzzi; G Fornari; E Santi; E Ballatori
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer.

Authors:  P Lissoni; E Tisi; S Barni; A Ardizzoia; F Rovelli; R Rescaldani; D Ballabio; C Benenti; M Angeli; G Tancini
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

4.  Chemotherapy of non-small cell lung carcinoma guided by an in vitro drug resistance assay measuring total tumour cell kill.

Authors:  D W Wilbur; E S Camacho; D A Hilliard; P L Dill; L M Weisenthal
Journal:  Br J Cancer       Date:  1992-01       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.